Detalles de la búsqueda
1.
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study.
BMC Cancer
; 24(1): 272, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38408958
2.
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.
Ann Oncol
; 34(4): 389-396, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709039
3.
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.
Dig Dis Sci
; 68(4): 1525-1528, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36315333
4.
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
Ann Oncol
; 33(12): 1269-1283, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089135
5.
Is intra-arterial hepatic chemotherapy painful?
Support Care Cancer
; 28(10): 4585-4587, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514617
6.
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors.
Ann Oncol
; 29(5): 1304-1311, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788155
7.
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma.
Ann Oncol
; 28(11): 2827-2835, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28950289
8.
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).
Ann Oncol
; 33(12): 1328-1331, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122799
9.
Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
Ann Oncol
; 27(2): 344-52, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598538
10.
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients.
Ann Oncol
; 32(12): 1642-1645, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34509616
11.
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Ann Oncol
; 27(12): 2268-2274, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733373
12.
Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer-results of a first-in-man dose-escalation study with a fixed-dose extension phase.
Ann Oncol
; 26(5): 1005-1011, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25646368
13.
Low skeletal muscle is associated with toxicity in patients included in phase I trials.
Invest New Drugs
; 32(2): 382-7, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24343673
14.
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.
ESMO Open
; 9(6): 103488, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38838500
15.
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma.
Invest New Drugs
; 31(6): 1530-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24077982
16.
Efficacy and tolerance of cetuximab in combination with 5 FU plus irinotecan based chemotherapy in metastatic squamous cell anal carcinoma.
Dig Liver Dis
; 55(3): 407-411, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36088220
17.
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients.
Cancer Chemother Pharmacol
; 92(3): 229-233, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354233
18.
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study.
ESMO Open
; 8(3): 101574, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244250
19.
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.
ESMO Open
; 6(5): 100270, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34547581
20.
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 26 Suppl 5: v56-68, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314780